Skip to content

A Study to asses the effectiveness of platelet rich plasma injection by intra-articular or rotator interval methods for management of periarthritis shoulder

A Randomised controlled trial to asses the efficacy of USG-guided platelet rich plasma injection by intra-articular vs rotator interval methods for management of periarthritis shoulder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032450
Enrollment
66
Registered
2021-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint

Interventions

Intervention1: Rotator Interval method: Under USG-guidance,3-4 ml of freshly prepared Platelet Rich Plasma will be injected by rotator interval method. Control Intervention1: Intra-articular method:

Sponsors

Lady Hardinge Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adults( >18years) with chronic shoulder pain for > 6 months 2.Average Numerical Pain Rating Scale (NRS) > 4

Exclusion criteria

Exclusion criteria: 1.Any steroid injection within last 8 weeks. 2.Patients having coagulopathies, skin infection over shoulder area and allergy to local anesthetics. 3.Any shoulder surgery or arthroscopy of the affected shoulder within the past one year.

Design outcomes

Primary

MeasureTime frame
Shoulder Pain and Disability Index (SPADI) at 0,1st and 3rd month in both the groups.Timepoint: 0,1st and 3rd month

Secondary

MeasureTime frame
1.Mean Numerical Pain Rating Scale(NRS) score at 0,1st and 3rd month follow-up in both the groups. 2.Proportion of patients with Post injection complications (infection or hematoma) at the site of injection in both the therapies.Timepoint: 0,1st and 3rd month

Countries

India

Contacts

Public ContactShubham Rahul Rai

Lady hardinge Medical College

nhayaran97@gmail.com9315175494

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026